Skip to content
NeuroTechGuide

Cognixion opens NIH-funded home study of its wearable BCI for people with ALS

The CHOICE study will compare the company's augmented-reality headset with eye-tracking tablets over 12 weeks in 30 adults with ALS.

In briefNon-invasiveClinical trials

Cognixion said on November 4 that it is enrolling 30 adults with ALS in CHOICE, an NIH-funded study run in participants’ homes across the US. Over 12 weeks, participants will use three options with a trained caregiver present: their own eye-tracking speech tablet, Cognixion’s head-worn brain-computer interface with augmented-reality glasses, and a touchscreen version.

The main measure is how much time people choose to spend with each option, which tests everyday preference and not only lab performance. Speed, accuracy, usability, quality of life and caregiver burden are secondary measures. The device is investigational and not FDA-approved, and no results are available yet.

Learn more: ALS · Cognixion in the Directory · Cognixion’s Apple Vision Pro study

Share:XLinkedInBlueskyEmail

More news